Not applicableStudy completedNCT07591753
What this trial is testing
Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)
Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)
European EGPA Study Group 591